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Structural studies of membrane proteins remain a great
experimental challenge. Functional reconstitution into artifi-
cial nanoscale bilayer disc carriers that mimic the native
bilayer environment allows the handling of membrane
proteins in solution. This enables the use of small-angle
scattering techniques for fast and reliable structural analysis.
The difficulty with this approach is that the carrier discs
contribute to the measured scattering intensity in a highly
nontrivial fashion, making subsequent data analysis challen-
ging. Here, an elegant solution to circumvent the intrinsic
complexity brought about by the presence of the carrier disc is
presented. In combination with small-angle neutron scattering
(SANS) and the D2O/H2O-based solvent contrast-variation
method, it is demonstrated that it is possible to prepare
specifically deuterated carriers that become invisible to
neutrons in 100% D2O at the length scales relevant to SANS.
These ‘stealth’ carrier discs may be used as a general platform
for low-resolution structural studies of membrane proteins
using well established data-analysis tools originally developed
for soluble proteins.
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1. Introduction
Despite significant recent breakthroughs in the field of
membrane-protein X-ray crystallography (Rasmussen et al.,
2007; Cherezov et al., 2007; Rosenbaum et al., 2007;
Rasmussen, Choi et al., 2011; Rasmussen, DeVree et al., 2011),
including the award of the 2012 Nobel Prize in Chemistry
to Lefkowitz and Kobilka for their contributions toward the
understanding of G-protein-coupled receptor systems (Roth
& Marshall, 2012), there is still an important lack of structural
insight into membrane proteins and their complexes (Bhat-
tacharya, 2009; White, 2009). This is most clearly illustrated by
the extremely low number of unique membrane-protein
structures available in the Protein Data Bank compared with
their 30% prevalence in the human proteome (Fagerberg et
al., 2010) and their importance as targets for about 50% of all
current drugs (Terstappen & Reggiani, 2001; Xia et al., 2006).
Of the 80 000 available protein structures to date, only 400
represent membrane proteins, with around a dozen of these
being human membrane-protein structures (Baker, 2010).
This creates an obvious need for alternative methods that
complement crystallography, nuclear magnetic resonance
(NMR) and (cryo) transmission electron microscopy (TEM)
approaches for this important class of drug targets.
Over the last decade, small-angle X-ray scattering (SAXS)
and small-angle neutron scattering (SANS) have become
increasingly important methods in structural studies of water-
soluble protein systems (Jacques & Trewhella, 2010; Petou-
khov & Svergun, 2012; Blanchet & Svergun, 2013; Rambo &
Tainer, 2013). Recent developments of these techniques at
synchrotron radiation and neutron beam sources, in combi-
nation with sophisticated sample-preparation procedures and
better, more robust and more general data-analysis software
tools (Konarev et al., 2006; Jacques et al., 2012), makes small-
angle scattering (SAS) an increasingly important tool for the
study of biomolecular systems. While SAS only has a struc-
tural resolution of the order of 10 A˚, which does not provide
information at the sorts of length scales accessible to protein
crystallography or NMR, it has the significant advantage of
allowing rapid protein studies in solution and native-like
environments. Furthermore, the solution properties may easily
be varied in a way that allows parametric studies such as those
relating to temperature, buffer conditions and pH (Round et
al., 2008; Toft et al., 2008; Hura et al., 2009). This is powerful
for studies of structural flexibility, which is of central impor-
tance in protein function, self-assembly and dynamic meta-
bolon formation. Previously, SAS studies have been carried
out using membrane proteins stabilized with detergent
micelles or liposomes (Chan & Boxer, 2007) or using more
advanced systems such as amphipoles (Pocanschi et al., 2006)
or nanodiscs (Nath et al., 2007). The requirements for sample
volumes and sample concentrations have been brought down
to about 10–20 ml at protein concentrations of a few milligrams
per millilitre for SAXS and 100–300 ml at a similar protein
concentration for SANS (Jacques & Trewhella, 2010). This
is compatible with what is typically attainable for many
membrane-protein systems (Midgett & Madden, 2007; Tate,
2010). Nevertheless, SAS has to date only provided limited
structural knowledge on membrane proteins despite a few
breakthroughs (Hunt et al., 1997; Berthaud et al., 2012;
Calcutta et al., 2012), mainly because it is difficult to extract
the low-resolution structure of the membrane protein alone
from SAS data measured on a complex multi-component
system.
We have now developed a versatile and robust methodology
to circumvent this intrinsic complexity through the use of the
well tested and structurally well defined nanodisc system for
membrane-protein reconstitution (Bayburt et al., 2002; Nath
et al., 2007; Ritchie et al., 2009). In combination with the D2O/
H2O-based contrast-variation method in neutron scattering
(Jacrot, 1976), we demonstrate that it is possible to control the
Escherichia coli-based biosynthesis of deuterated phosphati-
dylcholines as well as the expression of membrane-scaffolding
proteins to prepare specifically deuterated analogues of the
nanodisc which give a minimal contribution to the neutron
scattering data when used in 100% D2O. In this context, a
particular challenge has been to control the deuteration levels
in the phospholipid head and tail groups, respectively. The
stealth discs produced in this way should be generally usable
in low-resolution structural studes of many membrane
proteins and their complexes in solution. The analysis of
SANS data for this platform is greatly simplified and allows
the application of existing data analysis tools that are already
available for soluble proteins.
2. Materials and methods
2.1. Expression and purification of deuterated membrane-
scaffold protein MSP1D1 (D-MSP1S1)
D-MSP1D1 was overexpressed in E. coli strain BL21 (DE3)
using a pET-28a vector after an initial adaptation process
of the strain to minimal deuterated medium as described
previously (Artero et al., 2005). High cell-density cultures were
grown in 85% deuterated minimal medium containing glycerol
as a carbon source (Rochel et al., 2011). The protein was
purified according to a modified version of the established
method (Ritchie et al., 2009). All sets of protein lipid
deuteration were carried out in collaboration with the
Deuteration Laboratory PSB platform within the Life
Sciences Group at the Institut Laue–Langevin (ILL),
Grenoble, France.
2.2. Production and purification of deuterated
phosphatidylcholine
E. coli strain AL95 carrying the plasmid pAC-PCSlp-Sp-
Gm allowing the biosynthesis of phosphatidylcholine (PC;
Bogdanov et al., 2010) was adapted to minimal deuterated
medium according to previously established procedures
(Artero et al., 2005). Selective deuteration of PC with the
relevant scattering-length density was achieved by amplifying
the adapted starting culture in 100% deuterated minimal
medium (Artero et al., 2005) containing 0.2% arabinose
(Sigma–Aldrich), 5% deuterated glycerol (1,1,2,3,3-d5, 99%;
Eurisotop) and 2 mM deuterated choline chloride (trimethyl-
d9, 98%; Eurisotop). To obtain partial deuteration, hydro-
genated glycerol, as well as hydrogenated choline, were used
instead. After cultivation at 310 K for 24 h, the cells were
harvested by centrifugation and the total cellular lipids were
extracted by the method of Bligh & Dyer (1959). Lipid
extracts were separated into individual phospholipids using
silica-gel chromatography with varying ratios of chloroform
and methanol [9:1 (0.2 l), 4:1 (0.2 l), 1:1 (0.2 l), 1:4 (0.2 l) and
100% methanol (0.3 l)].
2.3. Phospholipid analysis
Phospholipid species were separated by thin-layer chro-
matography (TLC) using chloroform/ethanol/water/triethyl-
amine [30:35:7:35(v:v:v:v)] and identified by comparison with
known standards chromatographed on the same plate after
staining with primuline [5 mg primuline in 100 ml 80:20(v:v)
acetone:water; White et al., 1998]. For further analysis, lipid
spots were scraped off and extracted three times with 100 ml
chloroform/methanol/0.9% aqueous NaCl [1:1:1(v:v:v)]. The
lipid concentration was quantified by determination of the
total phosphorus as described previously (Rouser et al., 1966).
2.4. MALDI–TOF mass spectrometry
The extracted lipids were analysed using matrix-assisted
laser desorption/ionization time-of-flight (MALDI–TOF)
mass spectrometry as described previously (Schiller et al.,
2004). The lipid fractions were independently pre-mixed in a
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1:1(v:v) ratio with different matrix compounds [2,5-dihydroxy-
benzoic acid (DHB) and 9-aminoacridine (9-AA)] prior to
deposition onto the MALDI target and were investigated by
both positive and negative ion-mode MALDI–TOF MS on
a Bruker Autoflex mass spectrometer (Bruker Daltonics;
Petkovic et al., 2001). The lipids were also analysed subsequent
to PLA2 digestion in order to determine the fatty-acyl
composition, as described previously (Fuchs et al., 2007).
2.5. NMR spectroscopy
The locations of the incorporated deuterium atoms in the
lipid molecules were determined by 1H NMR through
comparison of 5% solutions of hydrogenated PC, of partially
deuterated PC synthesized with hydrogenated glycerol and
hydrogenated choline and of deuterated PC synthesized with
deuterated glycerol and deuterated choline all achieved in
E. coli. The lipids were dissolved in chloroform-d [99.96%,
0.03%(v:v) TMS as internal reference] and measured on a
300 MHz NMR spectrometer (Bruker).
2.6. Stealth carrier disc preparation
Liposomes were prepared by extrusion of the stealth PC
lipids in D2O buffer solution (20 mM Tris–HCl, 100 mM NaCl
pH 7.5) through 100 nm polycarbonate filters (Avanti Polar
Lipids Inc). Liposomes at different D2O:H2O ratios were
achieved through dilution of the D2O-based liposome stock
preparation with an adequate amount of H2O buffer solution
(20 mM Tris–HCl, 100 mM NaCl pH 7.5). This allowed lipo-
somes to be obtained at 60–100% D2O for subsequent SANS
measurements. The liposome size was confirmed through
dynamic light scattering on a BI-200SM System (Brookhaven
Instruments). Stealth nanodiscs were reconstituted using the
deuterated version of MSP1D1 together with the deuterated
stealth PC lipids through the previously described self-
assembly-based procedure (Ritchie et al., 2009). All SAXS
measurements were performed in H2O-based buffer. Prior to
the SANS measurements, the H2O-based buffer used in the
initial nanodisc preparation was substituted for a 100% D2O-
based buffer solution using centrifugal spin-filters with a
cutoff of 50 kDa (Millipore). To achieve the H2O:D2O ratios
required for the subsequent SANS measurements (60–100%
D2O), the nanodisc stock solution in 100% D2O was diluted
with an adequate amount of H2O buffer solution.
2.7. SANS contrast variation
All reported contrast-variation SANS data were collected
at 25C using the KWS1 instrument at the Forschungs-
Neutronenquelle Heinz Maier-Leibnitz (FRMII) in Munich,
while initial pilot data as well as the data from nanodiscs
prepared with commercially available POPC (Avanti Polar
Lipids Inc.) were obtained using the D11 instrument at the
Institut Laue–Langevin (ILL), Grenoble. All reported
measurements from FRMII were performed with 4.5 A˚
neutrons with a wavelength spread / of 10% FWHM. A
combination of two to three instrumental settings were used
to obtain a sufficiently wide q-range: high q-values (0.035–
0.45 A˚1) were covered with a sample-to-detector distance of
1.5 m and a collimation length of 4 m. Intermediate q-values
(0.0057–0.077 A˚1) were covered with a sample-to-detector
distance of 8 m and a collimation length of 8 m. Low q-values
(0.0022–0.03 A˚1) were covered with a sample-to-detector
distance of 20 m and a collimation length of 20 m. Owing to
the small size of the nanodiscs, these were only measured at
high and intermediate q-values, while the liposomes, which
have structural features ranging from the 40 A˚ bilayer
thickness to the 1200 A˚ liposome diameter, had to be
measured at all three settings. Absolute scale calibration was
performed using a calibrated Plexiglas sample as an external
reference and following the standard procedures at the facility.
Radial averaging, background subtraction and absolute scale
calibration to convert the data into scattering intensity I(q) in
units of cm1 as a function of momentum transfer q = 4sin/
(where  is the half scattering angle and  is the wavelength of
the incoming beam) was carried out using the QtiKWS soft-
ware (Pipich, 2007). Small resolution effects were present in
the SANS data, mainly owing to the non-negligible wave-
length spread of the incoming neutrons. These were taken into
account in the subsequent model-based data analysis by
smearing of the fit function with the calculated resolution
function (Pedersen et al., 1990). All samples were measured in
flat rectangular Hellma quartz cells. The samples in 85–100%
D2O were measured in cells with a path length of 2 mm,
whereas the samples in 60–80% D2O were measured in cells
with a path length of 1 mm in order to optimize the signal-to-
noise ratio and to minimize incoherent background and
multiple-scattering effects.
2.8. SAXS structural analysis
The nanodiscs were characterized by SAXS using the
Bio-SAXS instrument BM29 at the European Synchrotron
Radiation Facility (ESRF), Grenoble. All SAXS data were
collected at 20C at q-values ranging from 0.0040 to 0.45 A˚1
with q = 4sin/ using the fixed instrument setup described
for the now disassembled beamline ID14-3 (Pernot et al.,
2010), a predecessor of the current beamline. Data processing,
including radial averaging, background subtraction and
conversion of the data into I(q) (units of cm1) was performed
using the ATSAS package (Konarev et al., 2006). Calibration
of the scattering intensity into absolute units of cm1 was
performed using the forward scattering intensity of bovine
serum albumin prepared at a concentration of 3.2 mg ml1 as
an external reference. Resolution effects were considered to
be negligible owing to the very high monochromaticity of the
incoming beam, a very small beam diameter and close to
perfect collimation. The data were analysed using an estab-
lished approach for the nanodisc system (Skar-Gislinge &
Arleth, 2011; Skar-Gislinge et al., 2010).
2.9. Determination of forward scattering intensity I(0)
For each contrast measurement, the forward scattering
was estimated by the indirect Fourier transform method with
overlap optimization and background correction (Glatter,
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1977; Pedersen et al., 1994) and by taking the resolution effects
into account (Pedersen et al., 1990). The absolute scaled data
for the liposome and nanodisc samples were normalized by
sample concentration and the match points were derived in
the standard way (Stuhrmann, 1982) by fitting a second-order
polynomial to the forward scattering plotted as a function of
volume fraction of D2O in the buffer solution.
2.10. Model calculation of liposomes
The theoretical scattering signal for D64-POPC liposomes
was calculated using the same approach and Fortran77
implementation of the analytical model as previously
described in Andersen et al. (2011). However, to adapt the
calculations to the D64-POPC case, the following total lipid
scattering lengths, b, and partial specific molecular volumes, ,
were applied: PC head group, b = 6.0  1012 cm,  = 319 A˚3;
PO tail group, b = 6.4  1011 cm,  = 927 A˚3. The model
calculations assume that the liposomes are measured on a
background of 100% D2O with a scattering length density of
6.38  1010 cm2. An average liposome radius of 500 A˚ in a
Gaussian distribution with / = 0.25 was assumed, with a
liposome bilayer thickness of 40 A˚. This is an idealized model
calculation which does not take into account incoherent
background effects or other small effects that are typically
present in the experimental situation and that contribute to
the overall observed scattering.
2.11. Model calculation of protein scattering signal
The theoretical scattering signal for the epidermal growth
factor receptor (EGFR) was based on a combination of
available crystal structures (PDB entries 1ivo, 1nql, 2jwa, 1egf
and 2gs6) which were assembled manually using PyMOL
(v.1.5.0.4; Schro¨dinger) based on available structural infor-
mation for the system (Montelione et al., 1992; Ogiso et al.,
2002; Ferguson et al., 2003; Zhang et al., 2006; Bocharov et al.,
2008). Assuming one active dimer per nanodisc, the scattering
data were then calculated using the program CRYSON
(Svergun et al., 1998). The theoretical scattering signal for
CorA (PDB entry 2bbj; Lunin et al., 2006) was calculated using
CRYSON assuming one pentameric complex per disc. The
data were normalized in relation to the nanodisc data by
exploiting the fact that the absolute forward scattering
intensity for a dilute system of particles in solution can be
calculated as I(0) = nV2()2, where n is the concentration
(mol l1), V is the partial specific molecular volume of the
protein, which is 1.35 g cm3 (Mylonas & Svergun, 2007), and
 is the excess scattering-length density of the (hydro-
genated) protein in D2O, which is 3 1010 cm2 (Jacrot, 1976).
3. Results
3.1. The stealth nanodisc system: reaching invisibility
The theoretical deuteration levels required for total ‘invi-
sibility’ of the nanodisc system differ for the various compo-
nents of this lipid–protein particle. This results from natural
differences in the scattering-length density (SLD) between
proteins and phospholipids as well as between the head groups
and the fatty-acyl residues of the phospholipid bilayer alone
(Engelman & Moore, 1975; Jacrot, 1976). The SLD can be
calculated by summing over the scattering lengths of the single
atoms in a molecule and dividing by the partial specific
molecular volume (Glatter & Kratky, 1982).
A buffer based on 100% D2O is generally favoured in
SANS studies in order to minimize the hydrogen incoherent
scattering associated with the use of H2O (Jacrot, 1976).
Consequently, for the stealth membrane-protein carriers, zero
contrast in 100% D2O at all of the SANS-relevant length
scales is preferable to minimize both the hydrogen incoherent
scattering as well as the coherent signal arising from the
carrier molecules (Fig. 1).
For the prototype stealth nanodisc we have chosen a PC-
based lipid bilayer together with the membrane scaffold
protein MSP1D1 (Nath et al., 2007), as several successful
reconstitutions of membrane proteins have previously been
reported for this nanodisc system. We used PC composed of
mixed acyl unsaturated fatty-acyl residues of 16–18 C atoms in
length because these are physiologically the most relevant and
therefore are most often chosen as model bilayer lipids for the
reconstitution of membrane proteins (van Meer et al., 2008).
For a PC-based bilayer in 100% D2O we calculated that
total matching can be achieved when 78% of the head-group
atoms and 92% of the acyl-chain H atoms have been
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Figure 1
Schematic representation of the stealth nanodisc in buffer solution with a gradually increasing level of D2O (decreasing greyscale). (a) Hydrogenated
nanodisc consisting of a phospholipid bilayer (green) and membrane scaffold protein MSP (light blue). (b) Stealth nanodisc comprised of deuterated
lipid and deuterated MSP at 60% D2O. (c) Stealth nanodisc at 80% D2O. (d) Stealth nanodisc at 100% D2O.
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Figure 2
Selective deuteration of phosphatidylcholine in genetically modified E. coli. (a) Positive-ion MALDI–TOF spectra of purified phosphatidylcholine (PC)
obtained from a genetically modified E. coli strain grown in hydrogenated medium (trace H-PC), in deuterated medium supplemented with deuterated
glycerol and deuterated choline before (trace DglyDcho-PC) and after (trace DglyDcho-lysoPC) treatment with PLA2 as well as in deuterated medium
supplemented with hydrogenated glycerol and hydrogenated choline before (trace HglyHcho-PC) and after (trace HglyHcho-lysoPC) treatment with PLA2.
Peaks are marked with their m/z values and assignments are indicated. (b) NMR spectra showing H-PC (black), HglyHcho-PC (blue) and DglyDcho-PC
(green) with HDO representing water traces in the samples. (c) Molecular structure of the E. coli-produced PC (examples of the main species according
to deuteration).
exchanged to deuterium. For the membrane scaffold protein
MSP1D1 encircling the bilayer, as for all other proteins, the
required level of deuteration is reached when on average 70%
of the non-exchangeable H atoms are replaced by D atoms
(Engelman &Moore, 1975; Jacrot, 1976; Li et al., 2009). Owing
to the exchangeability of the H atoms bound to O, N and S
atoms, this leads to an overall level of deuteration of about
75% when the protein is dispersed in 100% D2O solution.
3.2. Engineering of the stealth-nanodisc components
While several versions of partially deuterated 1-palmitoyl-
2-oleoyl-PC and dipalmitoyl-PC (16:0/18:1 and 16:0/16:0,
respectively) are commercially available (Bragina & Chupin,
1997), monounsaturated mixed-acyl versions of PC with the
specific deuteration levels that would result in stealth prop-
erties in 100% D2O are not. This is because chemical synthesis
of these lipids is highly challenging (Bragina & Chupin, 1997).
Previous chemical syntheses of deuterated PC have utilized
methods that do not allow differentiation between the fatty-
acyl residues at positions 1 and 2 of the glycerol (Bragina &
Chupin, 1997). Selective deuteration of the head group in
unsaturated deuterated phospholipids is accompanied by
modifications of the double bonds (de Kruijff et al., 1978). We
therefore chose to produce the required PC lipids through
biological deuteration in a recently engineered E. coli strain
(AL95) that produces PC (Bogdanov et al., 2010). E. coli may
be deuterated to a very high degree (Paliy et al., 2003) and has
a very simple lipid composition (Raetz, 1978) compared, for
example, with yeast (Kaneko et al., 1976), and was therefore
chosen in order to facilitate biosynthesis as well as subsequent
extraction and lipid isolation.
Minimal medium was chosen for the production of both
deuterated nanodisc components in order to obtain better
control of the deuteration levels. For the bacterial lipids we
were able to achieve targeted head-group deuteration through
the addition of deuterated glycerol, while the deuteration of
the acyl chains could be controlled through the total level of
D2O in the growth medium. Also, the addition of commer-
cially available partially deuterated choline chloride retaining
a protonated ethylene group (trimethylammonium-d9)
enabled an additional level of control of head-group
deuteration. Furthermore, choline supplementation resulted
in higher yields of PC, as seen for its hydrogenated analogue
(Bogdanov et al., 2010).
The fatty-acyl distribution of E. coli phospholipids is
dependent on the growth conditions (de Mendoza et al., 1983).
For this particular strain, cells harvested in the stationary
growth phase resulted in a lipid extract containing 1-palmi-
toyl-2-palmitoleoyl-sn-glycero-3-phosphocholine (16:0/16:1
PC) as shown by positive-ion MALDI–TOF analysis (Fuchs
et al., 2010), with m/z 732.6 and 754.6 corresponding to the
proton and sodium adducts, respectively (Fig. 2a, trace H-PC).
The data also showed the presence of primarily PC with a
cyclopropane-modified fatty-acyl residue at m/z 746.6 and
768.6 (16:0/17:0cyc PC) typical of E. coli lipids (Magnuson et
al., 1993). These cyclopropanated residues appear to improve
stability and are less reactive to oxidative modifications than
the corresponding unsaturated fatty-acyl residues, while
keeping the overall membrane fluidity unchanged (Law, 1971;
Dufourc et al., 1983).
The PC biosynthesized in deuterated medium at 100%
D2O in the presence of deuterated glycerol and partially
deuterated choline chloride (trimethylammonium-d9) exhib-
ited a narrow distribution of highly deuterated PC with no
major changes in the fatty-acyl distribution (Fig. 2a, trace
DglyDcho-PC). The peaks at m/z 800.0 and 819.0 were assigned
to the H+ adducts of highly deuterated 16:0/16:1 PC and 16:0/
17:0cyc PC, respectively, whereas the two peaks at m/z 831.0
and 841.0 were assigned to the respective Na+ adducts of the
same two species. While the Na+ adduct of completely deut-
erated 16:0/17:0cyc PC (d80) should result in m/z 849.0, the
observed lower value of 841.0 for the most abundant species
can be explained by incompletely deuterated 16:0/17:0cyc
PC with a remaining average of eight H atoms
(C41H8D72NO8PNa). This interpretation was further
confirmed through characterization of the PC fraction after
digestion with phospholipase PLA2, an enzyme that selec-
tively cleaves the fatty-acyl residue in the sn-2 position (Fuchs
et al., 2007). Prior to digestion, the most abundant peak was at
m/z 841.0 and after digestion it was atm/z 562.6 (Fig. 2a, traces
DglyDcho-PC and DglyDcho-lysoPC). Fully deuterated lysoPC
16:0 would give a mass of 568.6 for the Na+ adduct; however,
the lower value of 562.6 observed for the most abundant
species can be assigned to a partially deuterated lysoPC
containing six H atoms (C24H6D44NO7PNa). This indicates a
loss of two H atoms after the deletion of the fatty-acyl residue
in the sn-2 position. The biosynthesis approach gave a narrow
distribution of deuteration level for PC, with an observed
standard deviation of 1.3 atomic mass units (amu) within the
single species. When compared with the 80 possible D atoms in
the 16:0/17:0cyc PC this corresponds to a 1.6% deviation in
the deuteration level for the overall lipid. The biosynthesis of
PC in 100% D2O in the presence of protonated carbon
sources showed a similar fatty-acyl distribution but with a shift
in m/z from 841.0 to 826.0 (Fig. 2a, trace HglyHcho-PC).
Assuming no change in fatty-acyl distribution, this decrease
of 15 amu corresponds well to the difference between the
protonated and deuterated carbon sources added to the
medium (choline possessing nine and glycerol five H atoms).
An exact decrease of 14 amu can be observed when comparing
the lyso fractions of both DglyDcho-PC and HglyHcho-PC
subsequent to PLA2 digestion, with a shift from m/z 562.6 for
a deuterated carbon-source preparation to m/z 548.5 for a
protonated carbon-source preparation (Fig. 2a, traces
DglyDcho-lysoPC and HglyHcho-lysoPC), indicating completely
hydrogenated head groups in this partially deuterated species.
The localization of the residual H atoms in the two afore-
mentioned deuterated versions of PC was investigated by 1H
NMR by comparison to the hydrogenated analogue (Fig. 2b).
The two signals observed at 4.04 and 4.50 p.p.m. in DglyDcho-
PC were in agreement with the ethylene H atoms of the
choline head group (Fig. 2b, trace DglyDcho-PC green).
Although they were slightly downfield-shifted compared with
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the hydrogenated sample, this assignment was confirmed by
13C NMR (65.9 and 60.3 p.p.m., respectively). If these two
aforementioned peaks are assumed to correspond to two H
atoms each, as is the case for the added choline, this gives a
total of approximately four H atoms in the fatty-acyl signal
at around 1.2 p.p.m. (Fig. 2b, green trace). NMR analysis of
HglyHcho-PC obtained from E. coli grown with hydrogenated
carbon sources, as shown in Fig. 2(b) (blue), confirmed head-
group incorporation of protonated glycerol and choline, while
the fatty-acyl residues remained highly deuterated. The
glycerol and choline signals between 3.5 and 5.5 p.p.m. were
identical to the hydrogenated sample, whereas the acyl signals
were similar to the highly deuterated sample. The many small
signals observed in NMR for the two deuterated analogues
(Fig. 2b, blue and green traces) are associated with the acyl
residues and indicate that the remaining H atoms were
randomly distributed throughout the chains. The combined
MALDI–TOF and 1H NMR data allowed the calculation of
the deuteration levels for the most abundant DglyDcho-PC
species 16:0/17:0cyc PC. For the 18 head-group H atoms
present in normal hydrogenated conditions, the remaining
four H atoms gave 78% deuteration. For the acyl chains, 58 of
the 62 H atoms were exchanged to deuterium, corresponding
to 93% deuteration. Fig. 2(c) illustrates examples of the most
abundant species before and after deuteration.
The stealth version of MSP1D1 with the ‘match-out’
deuteration level was expressed in E. coli BL21 (DE3) cells
grown in 85% deuterated minimal medium according to
established protocols for protein deuteration (Leiting et al.,
1998). The initial yields of the two nanodisc components
achieved using this approach were in the region of 50 mg l1
for deuterated PC and 25 ml1 for deuterated MSP1D1.
These amounts are sufficient for several nanodisc assemblies
that can be used in subsequent SAXS and SANS analysis.
Based on the amount of cell paste obtained in a pilot
fermentation study, this can be scaled up to over 200 mg l1
for PC. A similar scale-up is also expected to be possible for
MSP1D1 through fermentation.
3.3. Stealth carrier assembly and SANS contrast variation
Small unilamellar liposomes were prepared from purified
DglyDcho-PC (Supporting Fig. S1a
1). These stealth liposomes
showed an average diameter of 110 nm when probed by
dynamic light scattering. The liposome size was also confirmed
through SANS, in which model fitting (Kucerka et al., 2004)
and the pair distance distribution function, p(r), obtained by
indirect Fourier transformation gave a maximum dimension
of 120 nm (Fig. 3a, insert). Contrast-variation SANS data
collected over a broad q-range for the prepared liposomes at
increasing D2O content in the buffer showed a systematic
decrease in scattering intensity with increasing level of D2O
(Fig. 3a). The minimum in scattering intensity for the lipo-
somes derived from the SANS forward scattering as a function
of D2O content is observed to be close to 100% D2O (Fig. 3b).
A comparison of the scattering from the stealth liposomes to
the theoretically expected results for the commercially avail-
able D64-POPC deuterated lipids in 100% D2O is provided in
Fig. 3(c). The plot shows that the forward scattering of the
liposomes is minimized in the stealth lipid system. This is
expected, as the commercially available D64-POPC lipids are
not matched out at 100% D2O, which is the optimal contrast
in order to maximize the signal-to-noise ratio of an inserted
membrane protein. However, and more importantly, the
oscillation at intermediate to high q that is present in the
commercial system owing to the different internal scattering
length densities in the lipids is much less visible in the stealth
lipids. Since the scattering signal from a typical membrane
protein is expected to be present in this region (Fig. 5) this
is an important result. Fig. 3(c) also shows that while the
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Figure 3
Stealth liposome SANS contrast variation. (a) SANS data together with IFT fits showing the decrease in scattering intensity from the stealth liposomes
with the indicated increasing levels of D2O in the buffer. The inset shows the pair distance distribution function for stealth liposomes at 60% D2O. (b)
SANS forward scattering as a function of the D2O content of the buffer. Inset: a schematic representation of stealth liposomes with decreasing contrast in
D2O. (c) Stealth liposome SANS data (light purple) and theoretical SANS data calculated for liposomes with commercially available D64-POPC (Avanti
Polar Lipids; petrol). The insert shows a comparison of the two versions of deuterated liposomes (light purple and dark cyan) on a logarithmic scale.
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: KW5078).
biosynthetically produced lipids minimize the scattering from
the liposomes, the scattering intensity at 100% D2O is unfor-
tunately not zero. A complete I(q) = 0 is impossible to obtain
owing to internal deuteration fluctuations within the single
lipids. However, the data indicate that an even better match-
out could potentially be achieved through further fine-tuning
of the growth conditions. This will be pursued in future work.
SAXS analysis of deuterated MSP1D1 on its own showed
that the purified amphipathic protein belts formed large
disordered aggregates when dissolved in aqueous solution,
making subsequent SANS contrast-variation investigations
unreliable.
However, by combining the produced DglyDcho-PC
(Supporting Fig. S1a) and deuterated MSP1D1 (Supporting
Fig. S1b) using standard nanodisc-preparation procedures
(Ritchie et al., 2009), successful assembly of nanodiscs was
achieved. Size-exclusion chromatography showed an elution
profile (Supporting Fig. S1c) commonly observed for hydro-
genated nanodiscs (Ritchie et al., 2009). A small shoulder
observed on the chromatogram indicated that the ratio of
phospholipid to membrane-scaffold protein was not at the
optimal level for reconstitution. Non-optimal ratios can arise
from slight discrepancies in concentration measurements
when dealing with deuterated versions of the phospholipids
and MSP and would lead to fractions of slightly larger lipid–
protein aggregates. Therefore, only the fractions thought to
contain nanodiscs of typical size were used for further analysis
(Supporting Fig. S1c, green). Successful nanodisc assembly
was supported by SAXS analysis. The very distinct SAXS
curve characteristic of the nanodisc system (Fig. 4a, green)
gave a p(r) function that indicated a maximum size of
approximately 12 nm for the discs. This was consistent with the
previously observed size of nanodiscs with attached His tags,
which was also the case in this preparation (Skar-Gislinge et
al., 2010). Finally, a recently derived mathematical model
of the nanodisc (Skar-Gislinge et al., 2010; Skar-Gislinge &
Arleth, 2011) was fitted to the experimental data (Fig. 4a,
black) and confirmed that the SAXS data were fully consistent
with the nanodiscs having approximately the same structure as
has previously been observed by our group (Skar-Gislinge et
al., 2010; Skar-Gislinge & Arleth, 2011).
The SANS contrast-variation study of the stealth nanodisc
showed a systematic decrease in
scattering intensity with an
increasing level of deuterium in
the solvent and revealed a clear
minimum in the overall scattering
intensity at 100% D2O (Figs. 4b
and 4c). This initial preparation
of the stealth carriers resulted in a
small residual signal for both the
stealth liposomes and the nano-
discs. This could be owing to the
aforementioned statistical fluc-
tuations in the deuteration of the
lipids and the MSP1D1. The
observed intensity decreased to a
level only slightly above that of
the experimental background and
was therefore difficult to measure
accurately. In Fig. 4(d) we
compare the residual nanodisc
signal with the SANS signal of a
nanodisc assembled with D-
MSP1D1 in combination with
commercially available chemi-
cally synthesized D64-POPC
(Avanti Polar Lipids) containing
fully deuterated fatty-acyl chains
and protonated head groups.
While the forward scattering
signals from both of the deuter-
ated nanodisc samples are over
150-fold lower than that of a
protonated nanodisc (Fig. 4d,
inset), the biosynthesized stealth
nanodisc clearly shows an
improvement, with a lowered
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Figure 4
Stealth nanodisc assembly and SANS contrast variation. (a) Small-angle X-ray scattering data from
nanodiscs in H2O (green) shown together with the fitted structural model (black). The inset shows the pair
distance distribution function for the stealth discs with information about the disc size. (b) SANS data
together with IFT fits showing the decrease in scattering intensity from the stealth nanodiscs with the
indicated increasing buffer content of D2O in solution. (c) SANS forward scattering as a function of the
D2O content of the buffer. (d) Stealth nanodisc SANS data (light green) and SANS data measured for
nanodiscs assembled with D-MSP1D1 and commercially available D64-POPC (Avanti Polar Lipids; petrol).
The inset shows a comparison of the two versions of deuterated discs (light green and blue) with a
protonated version of the nanodisc (orange) on a logarithmic scale.
scattering intensity in the entire q-range when compared with
the chemically synthesized version of the disc. An even better
match-out could potentially be achievable through further
optimization of the deuteration levels of both the lipid bilayer
and the membrane-scaffold protein.
In order to obtain insight into the potential performance of
the developed stealth nanodiscs, a comparison of the residual
stealth nanodisc signal was performed with a range of possible
protein targets of different sizes (Fig. 5), where the theoretical
scattering intensity was generated using the program
CRYSON (Svergun et al., 1998). For EGFR, for which the
complete structure has yet to be resolved, the scattering data
were based on a manual assembly of the available structural
parts (Zhang et al., 2006; Ferguson et al., 2003; Bocharov et al.,
2008; Ogiso et al., 2002; Montelione et al., 1992), while for the
other proteins the curves were generated using already
available structural information (Palczewski et al., 2000;
Shintre et al., 2013; Pedersen et al., 2007; Shinoda et al., 2009;
Higgins et al., 2004). For larger protein complexes such as
EGFR with one active dimer per nanodisc, a 120-fold larger
forward scattering intensity could be observed for the protein
compared with the stealth nanodisc carrier, while for the CorA
pentameric complex (Lunin et al., 2006) the signal is 45-fold
larger than that of the stealth nanodisc. In such cases the signal
from the nanodisc can be ignored to the first order, allowing
the use of the stealth nanodisc system in combination with
already tested bead-modelling and rigid-body approaches
(Svergun, 1999; Svergun et al., 2001) to obtain a good low-
resolution determination of the membrane-protein structure.
In the case of smaller membrane-protein systems, it will be
beneficial to include a primitive model of the weakly scattering
stealth nanodisc in order to resolve the membrane-protein
signal. In all cases, combining the bead-modelling approach
with an approximate model of the weakly scattering stealth
nanodisc should make it possible to further improve the
structural resolution of the membrane protein towards the
standard 10 A˚ resolution that is typically achievable from
small-angle scattering data.
4. Discussion
We have shown that the deuteration level of physiologically
relevant PC can be separately controlled for head groups
and tails via a biosynthetic pathway. This includes targeted
substitution of hydrogen by deuterium in the different parts
of the phospholipid molecule through systematic addition of
deuterated nutrients during biosynthesis. We have exploited
this to prepare an advanced carrier system for membrane
proteins that becomes ‘invisible’ to neutrons in 100% D2O-
based buffers. This development offers a general approach to
determine the low-resolution structure of membrane proteins
and their complexes in solution using already established
SAXS/SANS data-analysis methods (Petoukhov & Svergun,
2012; Blanchet & Svergun, 2013).
Using this approach, the deuterated stealth carriers can be
produced in sufficiently large amounts to facilititate SANS-
based structural studies of membrane proteins that are
generally only available in small quantities (Midgett &
Madden, 2007; Tate, 2010).
The SAXS analysis of the prepared nanodiscs showed that
the overall disc structure did not change compared with POPC
nanodiscs that have been described previously (Skar-Gislinge
et al., 2010; Skar-Gislinge & Arleth, 2011). This confirmed that
the cyclopropane substitution of some of the double bonds
in the PC unsaturated fatty-acyl chain that occurs in E. coli
during the stationary growth phase (Magnuson et al., 1993)
and which should not affect the bilayer fluidity (Dufourc et al.,
1983) also did not affect nanodisc formation. Harvesting cells
in this growth phase is therefore recommended as it leads to
the highest biomass and consequently the highest yield of
phospholipid for the lowest cost of deuterated medium. The
fatty-acyl distribution can be regulated during the bacterial
growth cycle (Magnuson et al., 1993), creating additional
opportunities for the development of these stealth lipids.
The deuteration approach through biosynthesis also allows
the production of different types of specifically deuterated
physiologically relevant PCs that may be exploitable using
other structural techniques such as NMR and neutron reflec-
tometry. In NMR studies of complex protein–lipid systems a
complete cancellation of the 1H signal through the use of fully
deuterated PC leads to significant simplification in data
analysis (Hagn et al., 2013), while physiologically relevant PC
may provide better stability of the incorporated membrane
protein (van Meer et al., 2008). In neutron reflectometry, on
the other hand, the advantages lie in obtaining different
contrasts in different parts of the lipid bilayer, which can be
controlled through different deuteration levels, thus high-
lighting specific parts (Majewski et al., 2000). This can then be
exploited not only in studies of the effect of the lipid envir-
onment on membrane-protein systems but also in studies of
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Figure 5
Comparison of the stealth nanodisc SANS signal with those of model
proteins. SANS data from stealth nanodiscs in 100% D2O (green) and
D64-POPC nanodiscs (petrol) shown together with the theoretical
scattering signals for bovine rhodopsin (purple), ATP-binding cassette
transporter (ABCB10; orange), H+-ATPase (light blue), Na+/K+-ATPase
(green), trimeric TolC protein from E. coli (brown), bacterial magnesium
transporter CorA (dark blue) and the epidermal growth factor receptor
EGFR (dark red). All scattering curves were generated using CRYSON
and PDB entries available for each protein (PDB entries 1f88, 4ayw, 3b8c,
2zxe, 1tqq and 2bbj), while the EGFR structure was combined in PyMOL
(http://www.pymol.org) using PDB entries 1ivo, 1nql, 2jwa, 2gs6 and 1egf.
various ligands and potential drugs and their interactions with
the membrane (Akesson et al., 2012). In this context, using the
lipids to understand, for example, the interactions of anti-
microbial peptides with bacterial membranes could lead to
novel insights into the increasing problem of antibiotic resis-
tance in bacteria (Molloy, 2010).
In the case of the reported stealth nanodiscs and liposomes,
a residual signal is visible for both carriers when investigated
by SANS in 100%D2O. This signal is negligible by comparison
with that of a possible protein signal in 100%D2O, as shown in
the comparison of the nanodisc carrier with a range of model
membrane-protein signals. In these examples, the signal
caused by the nanodisc can to a good approximation be
ignored when reconstructing the low-resolution membrane-
protein structure from SANS data. However, for studies of
small membrane proteins with a size of 50 kDa, for which
the membrane-protein signal is also relatively weak in 100%
D2O, the residual nanodisc signal needs either to be incor-
porated in the data analysis or needs further reduction to
achieve the same negligibility.
Stealth liposomes naturally give a larger residual signal than
the nanodiscs owing to the much larger size of the particles.
However, they can be used as an alternative carrier for larger
membrane-protein systems where reconstitution into nano-
discs is not appropriate or where a more cell-like environment
is desired, for example in electrolyte or pH-gradient studies.
For accurate and reliable data interpretation in terms of the
structural parameters, the scattering data should be obtained
from a pure and well defined sample, as with any other systems
studied by SAS. As with regular nanodiscs, the reconstitution
conditions should be optimized for each membrane protein
under study (Ritchie et al., 2009). Based on the initial stealth
nanodisc assembly shown in this article, we do not foresee that
the reconstitution conditions will differ significantly for these
specifically deuterated nanodiscs. The use of D2O-based
buffer in SANS can in unfavourable cases give rise to greater
protein instability (Makhatadze et al., 1995), that may
compromise the SANS data quality.
Nevertheless, for membrane-protein complexes the
nanodisc-based approach of ‘mimicked solubility’ has already
led to an improved understanding of membrane-protein
function in a more native-like environment (Ritchie et al.,
2009) as well as structure, using for example NMR (Hagn et
al., 2013). We therefore anticipate that both the stealth
nanodiscs as well as the stealth liposomes will be a great
advantage as ‘neutron-invisible’ carriers to be used as a plat-
form for SANS structural studies of membrane proteins in
solution. Combined with the advancement of ab initio and
rigid-body modelling programs for structural data analysis and
the development of powerful next-generation neutron
sources, data obtained through this development may lead to
further insights into the dynamics, protein–ligand binding and
conformational changes of membrane proteins in a solution
environment. Collectively, this approach establishes an
experimental basis for using the system for low-resolution
structural studies of membrane proteins using the same data-
analysis tools as are already available for soluble proteins in
solution (Konarev et al., 2006; Petoukhov & Svergun, 2012;
Blanchet & Svergun, 2013).
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